Adverse effects, primarily cardiovascular in nature, are of concern because of their severe and possibly chronic nature.
The pathophysiology is not fully understood, rendering pharmacologic treatment difficult.
No true antidote for these agents has been developed, so patients requiring rapid reversal must be appropriately monitored and managed.
Caused by repetitive pressure on the median nerve, this is a leading cause of work-related disability.
Endometriosis is a chronic, recurrent disease caused by the extrauterine presence of endometrial tissues.
Up to 40% of patients undergoing chemotherapy with multiple agents experience nerve damage.
Clinicians must be able to recognize signs and symptoms of this potentially life-threatening condition.
Gastroparesis is a syndrome of delayed gastric emptying caused by factors other than mechanical obstructions in the stomach.
Pharmacists can oversee postprocedural treatment administered to prevent atrioesophageal fistula, a serious complication.
Liver cirrhosis is the end result of several mechanisms of liver inflammation caused by chronic liver disease, genetic disease, or autoimmune inflammation.
Many nonpsychiatric medications have the potential to cause neuropsychiatric events ranging from anxiety to psychosis.
Psychopathy is a serious personality disorder that can have significant negative effects both on individuals and on society.
It is often the behavioral symptoms associated with disease progression that lead to hospitalization.
This agent may be an alternative for patients with pain severe enough to require around-the-clock, long-term opioid therapy when other options are inadequate.
Five new molecular entities (riociguat, ibrutinib, obinutuzumab, coagulation factor XIII A-subunit [recombinant], collagenase clostridium histolyticum) that were recently approved by the FDA are discussed.
To effectively treat this skin condition, a healthcare professional must correctly identify the specific bacterium responsible.
For more articles, please check our archives.